Researchers analyze Real-World data on advanced throat cancer treatments
NCT ID NCT06771674
Summary
This study collected real-world information from 662 patients in the US with HPV-positive throat cancer that had returned or spread. Researchers analyzed how patients responded to standard treatments like pembrolizumab or nivolumab, with or without chemotherapy. The goal was to gather real-world evidence to help design better future clinical trials by comparing this data with results from controlled studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OROPHARYNGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cardinal Health
Dublin, Ohio, 43017, United States
Conditions
Explore the condition pages connected to this study.